Publications - BreakBio Corp.

Publications by BreakBio team members and advisors

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

December 7th, 2017

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target

August 30th, 2017

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention

July 31st, 2017

SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity

June 19th, 2017

Harnessing the Power of the Immune System to Target Cancer

January 1st, 2013

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

November 22nd, 2012

«
1
2
3
4
5
6
7
8
»